Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.7398
-0.0314 (-4.07%)
Mar 23, 2026, 4:00 PM EDT - Market closed

Curis Revenue

In the year 2025, Curis had annual revenue of $9.44M, down -13.43%. Curis had revenue of $1.14M in the quarter ending December 31, 2025, a decrease of -65.98%.

Revenue (ttm)
$9.44M
Revenue Growth
-13.43%
P/S Ratio
1.01
Revenue / Employee
$277,735
Employees
34
Market Cap
9.56M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.44M-1.47M-13.43%
Dec 31, 202410.91M885.00K8.83%
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 201810.43M530.00K5.35%
Dec 31, 20179.90M2.37M31.50%
Dec 31, 20167.53M-351.00K-4.46%
Dec 31, 20157.88M-1.97M-19.96%
Dec 31, 20149.84M-5.16M-34.39%
Dec 31, 201315.00M-1.97M-11.61%
Dec 31, 201216.97M2.21M14.97%
Dec 31, 201114.76M-1.24M-7.73%
Dec 31, 201016.00M7.41M86.26%
Dec 31, 20098.59M223.32K2.67%
Dec 31, 20088.37M-8.02M-48.95%
Dec 31, 200716.39M1.45M9.73%
Dec 31, 200614.94M8.93M148.83%
Dec 31, 20056.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioAtla11.00M
Bolt Biotherapeutics7.70M
BioLineRx1.18M
Iterum Therapeutics390.00K
Pulmatrix3.00K
Revenue Rankings